Adam Frymoyer

3.1k total citations
80 papers, 2.3k citations indexed

About

Adam Frymoyer is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Adam Frymoyer has authored 80 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pediatrics, Perinatology and Child Health, 24 papers in Pulmonary and Respiratory Medicine and 21 papers in Pharmacology. Recurrent topics in Adam Frymoyer's work include Neonatal and fetal brain pathology (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Neonatal Respiratory Health Research (15 papers). Adam Frymoyer is often cited by papers focused on Neonatal and fetal brain pathology (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Neonatal Respiratory Health Research (15 papers). Adam Frymoyer collaborates with scholars based in United States, Netherlands and Egypt. Adam Frymoyer's co-authors include Adam L. Hersh, Leslie Z. Benet, B. Joseph Guglielmo, Nageshwar Budha, Mark J. Dresser, Scott N. Holden, Paul L. Bollyky, Nadine Nagy, Hedwich F. Kuipers and Krisa P. Van Meurs and has published in prestigious journals such as Journal of Biological Chemistry, PEDIATRICS and Scientific Reports.

In The Last Decade

Adam Frymoyer

74 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Frymoyer United States 26 583 553 519 427 421 80 2.3k
Antonello Di Paolo Italy 34 472 0.8× 227 0.4× 376 0.7× 477 1.1× 410 1.0× 141 3.6k
Walid M. Awni United States 30 454 0.8× 602 1.1× 416 0.8× 221 0.5× 425 1.0× 139 3.0k
Richard A. Robson New Zealand 29 330 0.6× 270 0.5× 184 0.4× 173 0.4× 489 1.2× 87 2.8k
Leo Stolk Netherlands 23 623 1.1× 544 1.0× 216 0.4× 128 0.3× 202 0.5× 68 2.4k
Mario Regazzi Italy 36 430 0.7× 483 0.9× 869 1.7× 194 0.5× 631 1.5× 136 3.6k
Hassane Izzedine France 31 198 0.3× 331 0.6× 1.1k 2.0× 722 1.7× 735 1.7× 103 4.1k
Christopher Banfield United States 30 426 0.7× 411 0.7× 196 0.4× 94 0.2× 301 0.7× 88 2.8k
Ron J. Keizer Netherlands 20 386 0.7× 295 0.5× 254 0.5× 127 0.3× 306 0.7× 60 2.0k
Rob ter Heine Netherlands 26 404 0.7× 281 0.5× 727 1.4× 282 0.7× 309 0.7× 163 2.2k
Vijay Warty United States 27 152 0.3× 821 1.5× 313 0.6× 177 0.4× 301 0.7× 77 3.0k

Countries citing papers authored by Adam Frymoyer

Since Specialization
Citations

This map shows the geographic impact of Adam Frymoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Frymoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Frymoyer more than expected).

Fields of papers citing papers by Adam Frymoyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Frymoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Frymoyer. The network helps show where Adam Frymoyer may publish in the future.

Co-authorship network of co-authors of Adam Frymoyer

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Frymoyer. A scholar is included among the top collaborators of Adam Frymoyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Frymoyer. Adam Frymoyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swaminathan, Gayathri, Jianbo Ni, Cheng‐Yu Tsai, et al.. (2025). Why is the rectal route for NSAIDS favorable for preventing post-ERCP pancreatitis?. Pancreatology. 25(4). 491–498. 1 indexed citations
2.
Keleş, Elif, S. Ali, Pia Wintermark, et al.. (2025). Machine learning based clinical decision tool to predict acute kidney injury and survival in therapeutic hypothermia treated neonates. Scientific Reports. 15(1). 17278–17278.
3.
Spray, Beverly J., Nicholas Stence, Adam Frymoyer, et al.. (2024). Urine biomarkers of acute kidney injury and association with brain MRI abnormalities in neonatal hypoxic-ischemic encephalopathy. Journal of Perinatology. 44(8). 1203–1207. 1 indexed citations
4.
Ni, Jianbo, Gayathri Swaminathan, Monique T. Barakat, et al.. (2023). Rectal administration of tacrolimus protects against post-ERCP pancreatitis in mice. Pancreatology. 23(7). 777–783. 2 indexed citations
5.
Spray, Beverly J., Adam Frymoyer, Saritha Ranabothu, et al.. (2023). Renal oximetry for early acute kidney injury detection in neonates with hypoxic ischemic encephalopathy receiving therapeutic hypothermia. Pediatric Nephrology. 38(8). 2839–2849. 6 indexed citations
6.
Cohen, Ronald S., et al.. (2023). Fewer glucose checks and decreased supplementation using dextrose gel for asymptomatic neonatal hypoglycemia. Journal of Perinatology. 43(4). 532–537. 5 indexed citations
7.
Frymoyer, Adam, et al.. (2023). Impact of model‐informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(10). 1007–1014. 1 indexed citations
8.
Keleş, Elif, Pia Wintermark, Floris Groenendaal, et al.. (2022). Serum Creatinine Patterns in Neonates Treated with Therapeutic Hypothermia for Neonatal Encephalopathy. Neonatology. 119(6). 686–694. 12 indexed citations
9.
Spray, Beverly J., Valerie Y. Chock, Cara Slagle, et al.. (2021). Urine Biomarkers for the Assessment of Acute Kidney Injury in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia. The Journal of Pediatrics. 241. 133–140.e3. 21 indexed citations
10.
Chakkarapani, Ela, Sally Jary, David A. Menassa, et al.. (2021). Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment. EClinicalMedicine. 36. 100892–100892. 25 indexed citations
11.
Puopolo, Karen M., et al.. (2021). The Term Newborn. Clinics in Perinatology. 48(3). 471–484. 15 indexed citations
12.
Frymoyer, Adam, Neha S. Joshi, Ronald S. Cohen, et al.. (2020). Sustainability of a Clinical Examination-Based Approach for Ascertainment of Early-Onset Sepsis in Late Preterm and Term Neonates. The Journal of Pediatrics. 225. 263–268. 22 indexed citations
13.
Nagy, Nadine, Irina Gurevich, Hedwich F. Kuipers, et al.. (2019). 4-Methylumbelliferyl glucuronide contributes to hyaluronan synthesis inhibition. Journal of Biological Chemistry. 294(19). 7864–7877. 39 indexed citations
14.
Purohit, Prashant, Mohammed H. Elkomy, Adam Frymoyer, et al.. (2019). Antimicrobial Disposition During Pediatric Continuous Renal Replacement Therapy Using an Ex Vivo Model. Critical Care Medicine. 47(9). e767–e773. 16 indexed citations
15.
Keizer, Ron J., et al.. (2018). Model‐Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities. CPT Pharmacometrics & Systems Pharmacology. 7(12). 785–787. 87 indexed citations
16.
Elkomy, Mohammed H., David R. Drover, Jeffrey L. Galinkin, et al.. (2015). Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart Surgery. The AAPS Journal. 18(1). 124–133. 11 indexed citations
17.
Stockmann, Chris, Adam L. Hersh, Jessica K. Roberts, et al.. (2015). Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates. Infectious Diseases and Therapy. 4(2). 187–198. 49 indexed citations
18.
Frymoyer, Adam, Benjamin Rattray, C. Michael Cotten, et al.. (2014). Predictive Performance of a Gentamicin Population Pharmacokinetic Model in Neonates Receiving Full-Body Hypothermia. Therapeutic Drug Monitoring. 36(5). 584–589. 23 indexed citations
19.
Frymoyer, Adam, Adam L. Hersh, Zlatan Coralic, Leslie Z. Benet, & B. Joseph Guglielmo. (2010). Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: A Monte Carlo simulation. Clinical Therapeutics. 32(3). 534–542. 47 indexed citations
20.
Pierzga, Jane M., Adam Frymoyer, & W. Larry Kenney. (2003). Delayed distribution of active vasodilation and altered vascular conductance in aged skin. Journal of Applied Physiology. 94(3). 1045–1053. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonello Di Paolo Breakdown of academic impact, for papers by Walid M. Awni Breakdown of academic impact, for papers by Richard A. Robson Breakdown of academic impact, for papers by Leo Stolk Breakdown of academic impact, for papers by Mario Regazzi Breakdown of academic impact, for papers by Hassane Izzedine Breakdown of academic impact, for papers by Christopher Banfield Breakdown of academic impact, for papers by Ron J. Keizer Breakdown of academic impact, for papers by Rob ter Heine Breakdown of academic impact, for papers by Vijay Warty
Rankless by CCL
2026